TiGenix, S.A.U.;Consejo Superior De Investigaciones Cientificas;Universidad de Sevilla
发明人:
DELGADO, Mario,GONZALEZ-REY, Elena,BUESCHER, Dirk
申请号:
HUE09786159
公开号:
HUE029213T2
申请日:
2009.08.03
申请国别(地区):
HU
年份:
2017
代理人:
摘要:
The invention relates to the use of mesenchymal stem cells (MSCs) for treating systemic inflammatory response syndrome (SIRS) in a subject. The invention provides compositions, uses and methods for the treatment of SIRS.